By | December 26, 2013

Survey Finds OxyContin is Most Abused Prescription Drug

Prescription drugs affect the body in different ways. Opioids, for example are medications used to relieve pain. Also known as painkillers, these include: Codeine Diphenoxylate (Lomotil) Fentanyl (Duragesic) Hydrocodone (Vicodin, Lorcet, Lortab)… Read More

By | December 6, 2013

Study: Cholesterol-Lowering Statins Linked to Cataract Development

Results from a new study found that millions of adults who take popular statin medications to lower their cholesterol may be at increased risk of developing cataracts. Evidence found a link between… Read More

By | November 12, 2013

Help Make Generic Drug Manufacturers Accountable for Safety by Signing Take Justice Back Petition

FDA proposes rule changes to hold generic drug manufacturers accountable for injuries The FDA has proposed new rules that would improve generic drug manufacturer accountability. More than 80 percent of prescriptions are… Read More

By | October 29, 2013

Hawaii Dept. of Health Links Diet Supplement OxyElite Pro to Liver Failure

USPLabs, the manufacturer of the diet supplement called OxyELITE Pro, has halted distribution of the drug nationwide following multiple cases of liver failure linked to the supplement discovered by the Hawaii Department… Read More

By | October 25, 2013

FDA Issues Black Box Warning on Two Cancer Drugs

The hepatitis B warnings on two blood cancer drugs were recently strengthened by the Food and Drug Administration (FDA), according to Fox News. The strengthened warnings were issued to reflect the risk of… Read More

By | September 6, 2013

FDA Strengthens Warning on Lariam, Anti-Malaria Drug

Recently, the Food and Drug Administration (FDA) announced that the commonly used anti-malaria drug, called mefloquine hydrochloride (brand name Lariam) must have a “black box” warning on its label. The drug has… Read More

By | August 29, 2013

Study Links Calcium-Channel Blockers to Breast Cancer

Calcium-channel blockers (CCBs) may be associated with a higher risk of breast cancer, according to a new study. Published in the journal JAMA Internal Medicine, the study looked at the effects of the… Read More

By | July 31, 2013

Roche Halts Development of New Diabetes Drug Due to Safety Concerns

Swiss pharmaceutical giant Roche has stopped further development of its new diabetes drug called aleglitazar. This decision could increase safety concerns for drugs similar to aleglitazar, including the controversial medication called Avandia.… Read More

By | July 29, 2013

Advertising Nets Lipitor Better Sales Despite Dangerous Side Effects, Generic Competition

Pharmaceutical company Pfizer’s lucrative cholesterol drug Lipitor is expected to generate approximately $3 billion in revenue by 2015, according to a recent report by AARP’s Public Policy Institute. The cholesterol medication is… Read More

By | July 8, 2013

FDA To Revisit Rule Blocking Lawsuits Against Generic Drug Makers

The U.S. Food & Drug Administration has indicated it might allow generic drug manufacturers to revise their products’ safety labels independent of their name brand counterparts. If this change is made, consumers harmed by… Read More